NAFDAC warns against four medicines recalled in Pakistan

Nigeria’s medicines regulator has warned against four products recalled in Pakistan after quality checks found some batches adulterated or substandard.

The National Agency for Food and Drug Administration and Control said the warning applies to Nitras tablets, Kadin 2 tablets, Acefyl cough syrup and Loratadine 24 tablets. Pakistan’s Drug Regulatory Authority recalled the specified batches because of quality defects and contamination concerns.

NAFDAC said the medicines could cause reduced treatment effectiveness, unexpected adverse reactions and treatment failure. Patients using them for cardiac conditions, allergies, muscle spasms or cough-related illnesses could face increased risks.

The affected products include Nitras tablets containing glyceryl trinitrate, manufactured by Caraway Pharma in Rawat, batch 24L069, which were classified as substandard. Kadin 2 tablets, containing tizanidine hydrochloride and made by FYNK Pharma in Lahore, batch 569, were classified as adulterated. Acefyl cough syrup, containing acefylline piperazine and made by NABIQASIM Industries in Karachi, batch ACH479, was also classified as adulterated. Loratadine 24 tablets, containing loratadine and made by Murfy Pharma in Lahore, batch 24, received the same classification.

The agency said it had instructed zonal directors and state coordinators to conduct surveillance and remove the products if they appear in Nigeria. It urged health professionals, importers, distributors, pharmacies and consumers to avoid the medicines and buy only from authorised suppliers. Suspected sales of falsified or substandard medicines can be reported to NAFDAC on 0800-162-3322 or by email.

“

Healthcare professionals and consumers should avoid buying and using the recalled products.